Related Experiment Video
Updated: May 22, 2026

09:39
Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016
Study of doshic involvement in apasmara (epilepsy) and its utility
S Venkataraghavan1, V Rajagopalan, K Srinivasan
1Indian Institute of Panchakarma, P.O. Cheruthuruthy, Shornur - 679 531, India .
Ancient Science of Life
|May 5, 2012
Summary
This study analyzed 68 epilepsy cases to determine doshic dominance for prognosis. Vata or pitta dominant cases were most common, indicating a need for specific treatments.
Area of Science:
- Ayurvedic medicine
- Neurology
Background:
- Epilepsy is a neurological disorder with diverse etiologies.
- Ayurvedic principles classify diseases based on doshic imbalances (Vata, Pitta, Kapha).
Purpose of the Study:
- To assess the role of doshic dominance in epilepsy prognosis.
- To identify specific doshic patterns in epilepsy patients for targeted treatment.
Main Methods:
- Retrospective analysis of 68 epilepsy cases.
- Evaluation of doshic dominance (Vata, Pitta, Kapha) based on Ayurvedic principles.
Main Results:
- The majority of epilepsy cases exhibited Vata or Pitta doshic dominance.
- This suggests a correlation between specific doshic imbalances and epilepsy presentation.
Conclusions:
- Doshic assessment is valuable for understanding epilepsy prognosis in Ayurvedic practice.
- Tailoring treatments to address Vatahara or Píttahara needs may improve outcomes.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...

